Search Results

Riluzole 250 mg  | ≥98%

LKT Laboratories, Inc.

Benzothiazole; TRPC5 agonist, PTR1 inhibitor, voltage-gated Na+ channel blocker, GLT-1 modulator.

More Information Supplier Page

×

Riluzole

Riluzole 25 mg  | ≥98%

LKT Laboratories, Inc.

Benzothiazole; TRPC5 agonist, PTR1 inhibitor, voltage-gated Na+ channel blocker, GLT-1 modulator.

More Information Supplier Page

×

Riluzole

Risedronate Sodium Hydrate 100 mg  | ≥98%

LKT Laboratories, Inc.

Bisphosphonate; inhibits transfer of farnesyl pyrophosphate.

More Information Supplier Page

×

Risedronate Sodium Hydrate

Nedaplatin 50 mg  | ≥98%

LKT Laboratories, Inc.

Pt-based DNA cross-linker.

More Information Supplier Page

×

Nedaplatin

Nedaplatin 25 mg  | ≥98%

LKT Laboratories, Inc.

Pt-based DNA cross-linker.

More Information Supplier Page

×

Nedaplatin

Nedaplatin 10 mg  | ≥98%

LKT Laboratories, Inc.

Pt-based DNA cross-linker.

More Information Supplier Page

×

Nedaplatin

Rivastigmine Tartrate 1 g  | ≥98%

LKT Laboratories, Inc.

AChE and BChE inhibitor.

More Information Supplier Page

×

Rivastigmine Tartrate

Rivastigmine Tartrate 250 mg  | ≥98%

LKT Laboratories, Inc.

AChE and BChE inhibitor.

More Information Supplier Page

×

Rivastigmine Tartrate

Rivastigmine Tartrate 100 mg  | ≥98%

LKT Laboratories, Inc.

AChE and BChE inhibitor.

More Information Supplier Page

×

Rivastigmine Tartrate

Rocuronium Bromide 100 mg  | ≥98%

LKT Laboratories, Inc.

Non-depolarizing NMJ blocker; nAChR and M2/3 mAChR antagonist.

More Information Supplier Page

×

Rocuronium Bromide